Substance Dependence
📧 Sign up to get email alerts when something new happens for Substance Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3 [NA]
A Phase 3 trial updating on family engagement and cross-system linkage to substance use treatment for juvenile probationers has completed wi…
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Stress, Distress Intolerance, and Drug Dependence [NA]
A completed clinical trial investigating stress, distress intolerance, and drug dependence; results posted in 2019. No disease-specific outc…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Distress Tolerance Treatment for Substance Users [Phase 2]
Phase 2 clinical trial update for a distress tolerance treatment in substance dependence.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules. [Phase 1]
A Phase 1 healthy-volunteer study comparing the relative bioavailability of two capsule forms of GSK598809; the trial, sponsored by GlaxoSmi…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers [Phase 1]
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of single oral doses of GSK598809 in otherwise healthy smokers has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809 [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of repeat doses of GSK598809 for substance dependence. The trial h…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand [Phase 1]
This is a Phase 1 open-label PET imaging study to assess GSK618334 in healthy male volunteers using 11C-PHNO as the PET ligand. The trial ha…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: GSK618334 Repeat Dose Study [Phase 1]
GlaxoSmithKline's Phase 1 repeat-dose study of the investigational compound GSK618334 for substance dependence has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Evaluation of Impulsivity on Cocaine and Crack Addicts [NA]
A completed clinical trial evaluating the impact of impulsivity on individuals with substance dependence related to cocaine/crack use, spons…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment [Phase 2]
Phase 2 trial evaluating reinforcement of abstinence and continuing care in substance use disorder treatment; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use [Phase 3]
Phase 3 trial ASPIRE evaluating screening plus brief intervention to stop drug use has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices [Phase 3]
Phase 3 randomized trial evaluating initiation of methadone in primary care to prevent Hepatitis C transmission among individuals with subst…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) [Phase 4]
A randomized Phase 4 study evaluating the acceptability and safety of initiating Suboxone in heroin users; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2007-12-13Clinical Trial Update: Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia [Phase 4]
This Phase 4 trial update reports the completion of a study evaluating quetiapine (Seroquel) as therapy for substance use disorders in patie…
-
CLINICAL_TRIALS trial_result · 2007-06-11Clinical Trial Update: Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation [Phase 4]
A Phase 4 randomized trial compares ultrashort psychotherapy to sustained-release bupropion for smoking cessation; study status is completed…